Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease
PaperCitations, authors & open-access status
Comparison of Real-World Treatment Outcomes With Vedolizumab Versus Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 26 citations, 2019 year and gold oa status.
26
Citations
2019
Year
gold
OA Status